Empowering MYC carcinogenesis via RNA loops

Area of Science:

• Oncology
• Molecular Biology
• Gene Regulation

Background:

• The Myc oncogene is a critical driver of cell proliferation and tumorigenesis.
• Dysregulation of Myc contributes to various cancers, including breast cancer.
• Post-transcriptional modifications play a significant role in cancer development.

Purpose of the Study:

• To elucidate the intricate post-transcriptional regulatory circuits controlled by the Myc oncogene.
• To investigate the role of Myc-induced alternative splicing and translational control in breast cancer.
• To understand how these regulatory mechanisms influence cancer cell metabolism and stemness.

Main Methods:

• Analysis of gene expression data.
• RNA sequencing to identify alternative splicing events.
• Western blotting and polysome profiling for translational control assessment.
• Functional assays to evaluate metabolic reprogramming and stem cell-like properties.

Main Results:

• Myc oncogene significantly alters alternative splicing patterns in breast cancer cells.
• Myc influences mRNA translation efficiency, impacting protein synthesis.
• These post-transcriptional changes are linked to metabolic reprogramming, promoting a more aggressive cancer phenotype.
• Myc-driven regulation contributes to the acquisition of stem cell-like features in cancer cells, potentially affecting treatment resistance.

Conclusions:

• Myc oncogene orchestrates complex post-transcriptional regulatory networks.
• Alternative splicing and translational control are key mechanisms through which Myc promotes breast cancer progression.
• Targeting Myc-mediated post-transcriptional regulation may offer novel therapeutic strategies for breast cancer.